Dynamic Humeral Centering in Impingement Syndrome

Phase 3

Completed

• Conditions: Degenerative Rotator Cuff Disease With Impingement Syndrome
• Interventions: Procedure: Dynamic humeral centering; Procedure: Nonspecific mobilisation

• Registration Number: NCT01022775
• Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Brief Summary

The purpose of this study is to determine wether dynamic humeral centering is effective in patients with impingement syndrome of the shoulder

Detailed Description

Clinical trial with randomization for treatment and physiotherapist

Study Timeline

• Study Start: 2001-04
• Primary Completion: 2007-02
• Study Completion: 2007-02
• Status Verified: 2009-11
• Study First Submitted: 2009-11-30
• Study First Submitted QC: 2009-11-30
• Last Update Submitted: 2009-11-30
• Study First Posted: 2009-12-01
• Last Update Posted: 2009-12-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

• age > 30 years
• pain duration > 1 month
• presence of at least 2 positive impingement test results from Neer, Yocum and Hawkins testing
• total Constant score < 80.

Read More

Exclusion Criteria

concerning the shoulder

• stiffness
• anteroposterior instability
• tendinous calcification
• corticosteroid injection within the previous 30 days
• previous surgery
• humeral fracture
• inflammatory joint disease
• neoplastic disorders

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1: Dynamic humeral centering	Dynamic humeral centering	Dynamic humeral centering performed for 6 weeks, in 15 supervised individual outpatient sessions, plus daily home exercises for 12 months.
2: Nonspecific mobilisation	Nonspecific mobilisation	Nonspecific mobilisation performed for 6 weeks, in 15 supervised individual outpatient sessions, plus daily home exercises for 12 months.

Primary Outcome Measures

Name	Time	Method
Constant total score as a mean and by category	at 3 months

Secondary Outcome Measures

Name	Time	Method
Constant total score	at 12 months
Constant subscores for pain, activity, mobility and strength, and self-assessed disability on a 0- to 100-point visual analog scale, and analgesic and nonsteroidal anti-inflammatory drug (NSAID) use	at 12 months

Trial Locations

Locations (1)

Department of Rheumatology, Lariboisière Hospital; 🇫🇷 Paris, France